ScreenerHero
AAgilent Technologies, Inc.
NYSE · US · Healthcare · Diagnostics & Research · agilent.com
158.51USD+1.40%Mkt Cap: 44.14B $P/E: 31.45

Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates through three segments: Life Sciences and Diagnostics Mark…

Industry Peers

Diagnostics & Research
Screen all
TMO
Thermo Fisher Scientific Inc.
$226.85BUSDP/E 33.1
DAP
Danaher Corporation
$142.58BUSDP/E 38.5
DHR
Danaher Corporation
$151.78BUSDP/E 38.6
LONN
Lonza Group Ltd
$46.70BUSDP/E 37.9
NTRA
Natera, Inc.
$46.86BUSD
IDXX
IDEXX Laboratories, Inc.
$44.35BUSDP/E 39.5
IQV
IQVIA Holdings Inc
$41.03BUSDP/E 31.0
WAT
Waters Corporation
$40.83BUSDP/E 105.8
ILU
Illumina, Inc.
$30.40BUSDP/E 40.4
ILMN
Illumina, Inc.
$30.95BUSDP/E 38.2
MTD
Mettler-Toledo International, Inc.
$28.55BUSDP/E 32.1
LH
Labcorp Holdings Inc.
$26.80BUSDP/E 27.4
DGX
Quest Diagnostics Incorporated
$26.68BUSDP/E 25.6
GH
Guardant Health, Inc.
$21.92BUSD
MEDP
Medpace Holdings, Inc.
$16.98BUSDP/E 35.8
ERF
Eurofins Scientific SE
$13.65BUSDP/E 25.3
CRL
Charles River Laboratories International, Inc.
$13.84BUSD
RVTY
Revvity Inc. Common Stock
$13.33BUSDP/E 57.4
BIM
bioMérieux S.A.
$9.55BUSDP/E 19.1
QIA
Qiagen N.V.
$8.69BUSDP/E 22.8

Key Statistics

Company
Market Cap44.14B $
Enterprise Value45.88B $
Revenue (TTM)7.23B $
Gross Profit3.64B $
Net Income (TTM)1.30B $
Revenue/Share25.55 USD
Last Price158.51 USD
Fiscal Year EndOct 2025
MR QuarterApr 2026
Employees18.0K
CountryUS
SectorHealthcare
IndustryDiagnostics & Research
ISINUS00846U1016
Valuation
P/E (Trailing)31.45
P/E (Forward)23.65
PEG1.39
EV/EBITDA22.77
EV/Revenue6.34
P/S6.10
P/B6.19
EPS (TTM)5.00
EPS (Forward)6.61
52W Range
108.3597% of range160.27
52W High160.27 USD
52W Low108.35 USD
Profitability
Gross Margin52.43%
Oper. Margin23.71%
EBITDA Margin27.86%
Profit Margin18.75%
ROE19.33%
ROA10.24%
Growth
Revenue Growth10.00%
Earnings Growth60.00%
Cash Flow & Leverage
Operating CF1.56B $
CapEx (TTM)407.00M $
FCF Margin12.87%
FCF Yield2.11%
Net Debt1.74B $
Net Debt/EBITDA0.86
Balance Sheet
Debt/Equity0.50
Current Ratio2.10
Quick Ratio1.46
Book Value/Sh25.24 USD
Cash/Share6.398 USD
Dividends
Fwd Div Rate1.020 USD
Trail. Div Rate1.006 USD
Div. Yield0.66%
5Y Avg Yield0.69%
Payout Ratio20.20%
Ex-Div DateJun 30, 2026
Pay DateJul 22, 2026
Splits
Last Split1398:1000
Split DateNov 3, 2014
Analyst Consensus
Rating1.7 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)160.11 USD
Upside (mean)+1.0%
Target Range135.00 USD – 185.00 USD
$135.00+1.0% to mean$185.00
# Analysts19
Ownership
Shares Out.282.43M
Float281.46M
Insiders0.19%
Institutions95.25%
Short Interest
Short Ratio2.6d
Short % Float2.31%
Short % Out.2.04%
Shares Short5.75M
Short (prev mo.)5.33M
Technical
SMA 50136.97 (+15.7%)
SMA 200131.23 (+20.8%)
Beta1.23
S&P 52W Chg18.16%
Avg Vol (30d)1.38M
Avg Vol (10d)1.65M
Technical Indicators
RSI (14)76.9
MACD4.9230
MACD Signal3.9356
MACD Hist.+0.9874
BB Upper154.90 USD
BB Middle142.09 USD
BB Lower129.28 USD
BB Width18.03%
ATR (14)4.136 USD
Vol Ratio (20d)1.95x